Dr Evan Newell

Evan Newell completed his B.Sc. in Immunology at McGill University and Ph.D. in Physiology at the University of Toronto. As a post-doc at Stanford University with Mark Davis he worked on biophysical aspects of T cell antigen recognition and initiated the use of mass cytometry for the study of human T cell responses. Now as a principal investigator at the Singapore Immunology Network (SIgN), his lab continues to apply and develop novel approaches for identifying and thoroughly characterizing antigen-specific T cells. This includes the development of combinatorial peptide-MHC tetramer staining used in conjunction with mass cytometry for in-depth analysis of cellular phenotype and function. A major goal of lab is to identify useful biomarkers of clinical outcomes that take advantage of these modern approaches with particular focus on human chronic infection and cancer.